Stay updated on APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The history adds a Terminated status and indicates Results Posted with new Outcome Measures (Results). A new Revision: v3.3.2 entry dated 2025-11-21 is recorded.
    Difference
    0.6%
    Check dated 2025-11-25T13:55:46.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice that was previously displayed on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T07:24:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    A new history version (version 39) was added for NCT02706353 on 2025-10-08, indicating ongoing Quality Control Review and a results return date of 2025-10-23.
    Difference
    2%
    Check dated 2025-10-27T20:56:11.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    9%
    Check dated 2025-10-06T07:58:00.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. This is a metadata revision with no substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-29T04:28:57.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the Back to Top element was removed with no substantive content changes detected.
    Difference
    0.6%
    Check dated 2025-09-14T21:54:36.000Z thumbnail image

Stay in the know with updates to APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APX005M + Pembrolizumab in Metastatic Melanoma Clinical Trial page.